Rituxan - rituximab
Navigation: NDC > Supplier starting with: G > GENENTECH, INC.| Field | Value |
|---|---|
| NDC Code: | 50242-051 |
| Proprietary Name: | Rituxan |
| Suffix: | |
| Non-Proprietary Name: | rituximab |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 26-11-1997 |
| Category Name: | BLA |
| Application Number: | BLA103705 |
| Labeler: | GENENTECH, INC. |
| Substance Name: | RITUXIMAB |
| Active Numerator Strength: | 10 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | CD20-directed Antibody Interactions [MoA],CD20-directed Cytolytic Antibody [EPC] |
| DEA Schedule: |